Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The specificity and clinical relevance of nine antimitochondrial antibodies (AMA) - anti-M1 to anti-M9 - are described. All nine AMA types react with antigens which are associated either with inner (M1, M2, M7) our outer mitochondrial membranes (M3, M4, M5, M6, M8, M9) derived from rat liver or beef heart mitochondria. These antigens can be clearly distinguished by their different physical and chemical properties. Anti-M1 to anti-M9 can be related to distinct clinical entities: anti-M1, anti-M5, and anti-M7 are found in nonhepatic disorders, such as syphilis (anti-M1), undefined collagen diseases (anti-M5), and some forms of cardiac diseases (anti-M7). Anti-M3 and anti-M6 are detected in drug-induced disorders, such as phenopyrazon-induced pseudolupus syndrome (PLE; anti-M3) and iproniazid-induced hepatitis (anti-M6). Anti-M2, anti-M4, anti-M8, and anti-M9 are confined to primary biliary cirrhosis (PBC). Anti-M2 is a specific marker for the diagnosis of PBC; 96% of PBC patients (n = 752) were anti-M2 positive. Anti-M4 and anti-M8 seem to reflect disease activity. Anti-M9 antibodies occur preferentially in early PBC. The clinical course of PBC was analyzed with respect to four different AMA profiles: profile A: only anti-M9 positive in the ELISA; profile B: anti-M9 and anti-M2 positive in the ELISA; profile C: anti-M2 positive in ELISA and complement fixation test (CFT), but anti-M4 and anti-M8 positive only in the ELISA; and profile D: anti-M2, anti-M4, anti-M8 positive in EL…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nine of these anti-mitochondrial antibodies (AMA-M1 to AMA-M9) have been identified and named according to their specific characteristics (that is, the targets, pathological context of detection, appearance by indirect immunofluorescence (IIF), band labelling by western blot and ability to bind to complement)229–231.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“AMA-M1 are a group of aCL antibodies that are directed solely towards cardiolipin229.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“AMA profiling of patients with PBC has enabled researchers to improve both diagnosis and prognosis of the disease229,237.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“Detection of AMA (i.e. AwMA, AmtDNA, AmtRNA. IgG and IgM) was performed by our research laboratory, as previously published (11)”
From Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus (2022) · cites this paper as [11]
In the citing paper
“Antibodies targeting mitochondrial components other than mtDNA are also found in SLE. They include anti-cardiolipin [AMA-M1, also known as anti-cardiolipin antibodies (ACA)], anti-60kDa heat shock protein (anti-HSP60), as well as AMA-M3 and AMA-M5 antibodies.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [34]
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385 · cited 1×
“In contrast to the ELISA method, in the immunoblot method the reaction of antibodies with different antigenic determinants can be visualized [31].”
MethodRaza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
ENZYMATIC PROPERTIES OF THE INNER AND OUTER MEMBRANES OF RAT LIVER MITOCHONDRIA
Schnaitman, C., & Greenawalt, J. W. (1968) · The Journal of Cell Biology · doi:10.1083/jcb.38.1.158 · Cited by 1,386 · cited 1×
“Separating inner and outer mitochondrial membranes following the digitonin method of Schnaitman and Greenawalt [28], the M6-antigen copurified with the outer membrane fraction.”
BackgroundSEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
WALKER, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91372-3 · Cited by 507 · cited 3×
“Anti-M2 sera give a very typical IFL pattern [32], showing a bright staining of renal distal tubules.”
BackgroundMethodChristensen, E., Crowe, J., Doniach, D., Popper, H., Ranek, L., Rodés, J., Tygstrup, N., & Williams, R. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90571-5 · Cited by 273 · cited 1×
“AMA have been found in more than 90% of patients with PBC and titers measured in IFL or CFT did not greatly vary when patients were followed for many years [8].”
BackgroundPRIMARY BILIARY CIRRHOSIS IS A DRY GLAND SYNDROME WITH FEATURES OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Epstein, O., Thomas, H. C., & Sherlock, S. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91621-9 · Cited by 224 · cited 1×
“Thus, PBC was also described as a "dry gland syndrome" [ 9 ] affecting not only bile ducts but also ducts of the pancreas or salivary gland.”
BackgroundKoike, T., Sueishi, M., Funaki, H., Tomioka, H., & Yoshida, S. (1984) · PubMed · Cited by 192
Lindenborn-Fotinos, J., Baum, H., & Berg, P. A. (1985) · Hepatology · doi:10.1002/hep.1840050510 · Cited by 161
Self-citation(1984) · PubMed Central · Cited by 153
Self-citationBerg, P. A., Lindenborn-Fotinos, J., Klein, R., & Klöppel, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91327-7 · Cited by 144
Self-citation
Research works printed but not linked: 3
- Berg PA, Traunecker U, Märker A (1973) Mitochondriale Antikörper bei nicht hepatischen Krankheiten. Dtsch Med Wochenschr 98:1186–1188
- Berg PA, Weber P, Oehring J, Lindenborn-Fotinos J, Stechemesser E (1985) Significance of different types of mitochondrial antibodies in primary biliary cirrhosis. In: H Brunner, H Thaler (eds) Hepatology: A Festschrift für Hans Popper. Raven press, New York, pp 231–242
- Klein R, Schultheiß HP, Berg PA (1984) Nachweis von organspezifischen antimitochondrialen Antikörpern (Anti-M9) bei Patienten mit primär-biliärer Zirrhose. Verh Dtsch Ges Inn Med 90:910–913
Cited by
SZOSTECKI, C., WILL, H., NETTER, H. J., & GULDNER, H. H. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03224.x · Cited by 364
Van de Water, J., Gershwin, M. E., Leung, P., Ansari, A., & Coppel, R. L. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1791 · Cited by 279
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Autoantibodies in Heart Failure and Cardiac Dysfunction
Kaya, Z., Leib, C., & Katus, H. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243360 · Cited by 187
Moteki, S., Leung, P. S., Coppel, R. L., Dickson, E. R., Kaplan, M. M., Munoz, S., & Gershwin, M. E. (1996) · Hepatology · doi:10.1002/hep.510240117 · Cited by 152
The non-haemostatic role of platelets in systemic lupus erythematosus
Linge, P., Fortin, P. R., Lood, C., Bengtsson, A. A., & Boilard, É. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.38 · Cited by 141
The biochemical basis of mitochondrial diseases
Scholte, H. R. (1988) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00768393 · Cited by 98
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.004 · Cited by 61
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59
Pelletier, M., Breton, Y., Allaeys, I., Becker, Y. L. C., Benson, T., & Boilard, É. (2023) · Transfusion · doi:10.1111/trf.17524 · Cited by 51
“Antibodies that target mitochondria are also described in primary biliary cirrhosis and anti-phospholipid syndrome.(35,60) Whether these antibodies prevent beneficial roles played by extracellular mitochondria or whether they promote exchange between certain cellular types is unknown.”
11 Immunology of primary biliary cirrhosis
Berg, P. A., & Klein, R. (1987) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(87)90053-4 · Cited by 50
Self-citationLiu, L., & Deng, Q. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335825 · Cited by 31
“In addition, the adaptive immune system participates in proinflammatory processes through antimitochondrial antibodies (Berg and Klein, 1986). mtDNA can be contained by immune complexes; these extracellular DNA-containing immune complexes are captured by Fcγ receptors, thereby activating the cyclic…”
BackgroundAutoimmune tests in primary biliary cirrhosis
Strassburg, C. P., & Manns, M. P. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0105 · Cited by 30
Becker, Y. L. C., Gagné, J., Julien, A., Lévesque, T., Allaeys, I., Gougeard, N., Rubio, V., Boisvert, F., Jean, D., Wagner, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42082 · Cited by 26
“with APS or PBC (Figure 3A), 2 diseases in which AMAs have been reported (11,14).”
BackgroundInfluentialPrimary Biliary Cholangitis and Autoimmune Hepatitis
González, R. S., & Washington, K. M. (2018) · Surgical pathology clinics · doi:10.1016/j.path.2018.02.010 · Cited by 42
Jang, J. S., Juran, B. D., Cunningham, K. Y., Gupta, V. K., Son, Y. M., Yang, J. D., Ali, A. H., Enninga, E. A. L., Sung, J., & Lazaridis, K. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-69358-4 · Cited by 26
Konishi, H., Fukuzawa, K., Mori, S., Satomi‐Kobayashi, S., Kiuchi, K., Suzuki, A., Yano, Y., Yoshida, A., & Hirata, K. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.8183 · Cited by 24
“To date, nine mitochondrial antigens (M1M9) have been reported to stimulate the production of the corresponding antibodies, AMA-M1 to AMA-M9 (2).”
BackgroundMolecular Aspects and the Pathological Basis of Primary Biliary Cirrhosis
Leung, P. S. C., de Water, J. V., Coppel, R. L., Nakanuma, Y., Munoz, S., & Gershwin, E. M. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0015 · Cited by 22
A Case of Autoimmune Hypophysitis Associated with Asymptomatic Primary Biliary Cirrhosis.
Nishiki, M., Murakami, Y., Koshimura, K., Sohmiya, M., Tanaka, J., YABE, S., Kobayashi, I., & Kato, Y. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.697 · Cited by 17
5 Immunopathology of primary biliary cirrhosis
Galperin, C., & Gershwin, M. E. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90053-6 · Cited by 17
Li, H., Liu, S., Wang, X., Feng, X., Wang, S., Zhang, Y., Zhang, F., Wang, L., Xu, T., & Li, Y. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0416 · Cited by 15
“According to the location of antigens on the inner or outer membrane of mitochondria, sensitivity to trypsin, and electrophoretic characteristics, the target antigens of AMA can be divided into 9 subtypes (M1 to M9) 3 .”
Clinical Relevance of Antiphospholipid Antibodies in Primary Biliary Cirrhosis
von Landenberg, P., BAUMGARTNER, M., Schöelmerich, J., Lackner, K. J., & Klein, R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.043 · Cited by 14
Self-citationUncommon types of autoantibodies – Detection and clinical associations
Staruszkiewicz, M., Pituch‐Noworolska, A., & Skoczeń, S. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103263 · Cited by 17
Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.
Provenzano, G., Diquattro, O., Craxì, A., Almasio, P. L., Pinzello, G., Marino, L., Fiorentino, G., Rinaldi, F. M., & Pagliaro, L. (1993) · Gut · doi:10.1136/gut.34.4.544 · Cited by 14
Transplantation in primary biliary cirrhosis
Sallie, R., O'GRADY, J., & Williams, R. L. (1991) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1991.tb00909.x · Cited by 12
Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome
Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É., & Fortin, P. R. (2020) · Lupus · doi:10.1177/0961203320944481 · Cited by 11
Zandanell, S., Straßer, M., Feldman, A., Strebinger, G., Aigner, G., Niederseer, D., Laimer, M., Mussnig, B., Paulweber, B., Datz, C., et al. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1885945 · Cited by 11
“Cardiovascular events and nonhepatic malignancies (both n = 9) were the most common causes of death in AMA-positives without PBC, whereas sepsis and pneumonia (n = 2) were the dominant causes in the PBC group.”
BackgroundDilated cardiomyopathy with anti-mitochondrial M2 antibody: A case series
Kazama, S., Kondo, T., Ito, R., Kimura, Y., Kuwayama, T., Hiraiwa, H., Morimoto, R., Okumura, T., & Murohara, T. (2023) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2023.02.021 · Cited by 8
Metoprolol-induced Severe Liver Injury and Successful Management with Therapeutic Plasma Exchange
Philips, C. A., Paramaguru, R., Mahadevan, P., Ravindranath, J., & Augustine, P. (2017) · Cureus · doi:10.7759/cureus.1209 · Cited by 11
“Antibodies to the mitochondrial type are of seven types (M1 to M7) and are associated with many conditions: for example, anti-M2, M4, M8, and M9 - primary biliary cirrhosis; M2 autoimmune hepatitis; M3 - drug-induced lupus erythematosus, and M6 - drug-induced hepatitis [7].”
BackgroundSyphilis Hepatitis Presenting as a Mimic of Primary Biliary Cholangitis
Kern, C., Elmoursi, A., Blake, C. M., & Hoellein, A. R. (2020) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000497 · Cited by 7
“Similarly, syphilis has previously been described to cause an elevation in other nonspecific mitochondrial antibodies (particularly anti-M1 AMA) but not anti-M2 AMA.(12,13)”
BackgroundJong-Hon, K., Yajima, R., Karino, Y., Yoshida, J. I., Tsuji, K., Watanabe, S., Horada, K., Itoh, Y., Sekiguchi, K., Toyoda, S., et al. (2001) · Hepatology Research · doi:10.1016/s1386-6346(01)00075-4 · Cited by 4
Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets
Mimura, S., Morishita, A., Oura, K., Yano, R., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., Tatsuta, M., Himoto, T., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238503 · Cited by 4
“AMAs also react with other members of the 2-oxoacid dehydrogenase complex family, including the branched-chain 2-oxoacid dehydrogenase E2 (BCOADC-E2) and the α -ketoglutarate dehydrogenase E2 (OGDC-E2) [15,16].”
菊池, 健. (2000) · Hepatology Research · doi:10.1016/s1386-6346(99)00053-4 · Cited by 3
Mitochondrial transplantation and its impact on infectious disease progression: a pilot studyPreprint
Benson, T., Patel, S. P., Albensi, B. C., Mahajan, V. B., Adlimoghaddam, A., Sikora, S., & Saitō, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556161 · Cited by 3
Antimitochondrial antibodies in the antiphospholipid syndrome
Abuaf, N., Laperche, S., Carsique, R., Meyer, O., Deschamps, A., Rajoely, B., Johanet, C., & Homberg, J. (1995) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02772249 · Cited by 1
Strassburg, C. P., & Manns, M. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_9 · Cited by 1
Primary Biliary Cirrhosis: Pathology
MacSween, R. N. M. (1989) · Springer eBooks · doi:10.1007/978-1-4684-7041-3_15
The Great Mimicker Strikes Again
Taliano, R., Godfrey, M. S., Garland, J. M., Taylor, L. E., Wood, S., & Resnick, M. B. (2017) · AJSP Review and Reports · doi:10.1097/pcr.0000000000000196
怕孜来提, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13102327
Mitochondrial antigens: their presentation and related diseases
Zhang, S., & Su, S. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2781-x
“…proteins, such as the E2 component of the pyruvate dehydrogenase complex (PDC-E2), the MLRQ subunit of NADH ubiquinone oxidoreductase, sulfite oxidase, glycogen phosphorylase, sarcosine dehydrogenase and monoamine oxidase (Becker et al., 2019a; Becker et al., 2019b; Berg and Klein, 1986).”
InfluentialThe Role of Antimitochondrial Antibodies in Atrial Cardiomyopathy
Showkathali, R., & Valappil, S. P. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.107485
Case Report: Two atypical cases of M6-like antimitochondrial antibody pattern unlinked to iproniazid
Tolmer, E., Bonnet, B., Jeannin, G., Junda, M., Godignon, M., & Evrard, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1675688
Shi, X., Han, X., Liu, Y., & Zhao, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1796837
“AMA-M7 and AMA-M8 subtypes are limited to distal renal tubular epithelial cells (35, 38, 39).”
InfluentialSerologische Diagnose autoimmuner Lebererkrankungen
Berg, P. A., & Klein, R. (1987) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-85460-6_54
Self-citation
Metadata
- Authors
- Berg, P. A., & Klein, R.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- ORCID
- Klein, R.
- Venue
- Klinische Wochenschrift
- Published
- 1986-10
- Volume
- 64
- Issue
- 19
- Pages
- 897-909
- ISSN
- 0946-2716 (ISSN-L)
- 0023-2173
- 1432-1440
- OpenAlex
- W2007048294
- Cited by
- 48
- References
- 33
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2012: 2
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- antimitochondrial antibodies, anti-M2 antibodies, primary biliary cirrhosis, mitochondrial antigens, mitochondrial outer membrane, inner mitochondrial membrane, drug-induced liver injury, connective tissue diseases, syphilis, heart disease, disease activity markers, antibody profiles, cross-reactive antigens, complement fixation test
- MeSH terms
- Antibody Specificity, Autoantibodies, Autoantigens, Cardiolipins, Collagen Diseases, Fluorescent Antibody Technique, Humans, Liver Cirrhosis, Biliary, Lupus Erythematosus, Systemic, Mitochondria, Mitochondria, Liver, Cardiomyopathies, Myocarditis, Prognosis, Syphilis, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.